Your browser doesn't support javascript.
Risk of Severe COVID-19 Disease and the Pandemic's Impact on Service Utilization Among a Longitudinal Cohort of Persons with HIV-Washington, DC.
Monroe, Anne K; Xiao, Jiayang; Greenberg, Alan E; Levy, Matt E; Temprosa, Marinella; Resnik, Jenna B; Castel, Amanda D.
  • Monroe AK; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, NW, Washington, DC, 20052, USA. amonroe@gwu.edu.
  • Xiao J; Department of Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
  • Greenberg AE; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, NW, Washington, DC, 20052, USA.
  • Levy ME; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, NW, Washington, DC, 20052, USA.
  • Temprosa M; Department of Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
  • Resnik JB; Westat, Rockville, MD, USA.
  • Castel AD; Department of Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
AIDS Behav ; 26(10): 3289-3299, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-1787836
ABSTRACT
People with HIV (PWH) have a high burden of medical comorbidities, potentially putting them at increased risk for severe COVID-19. Additionally, during the COVID-19 pandemic, HIV care delivery has been restructured and the impact on HIV outcomes is unknown. The objectives of this study were first, to examine the risk of severe COVID-19 among PWH, using a definition incorporating clinical risk factors, and second, to examine the pandemic's impact on HIV care. We used data from the DC Cohort, a large cohort of people receiving HIV care in Washington, DC. We found that a high proportion of participants across all age groups qualified as increased (58%) or high risk (34%) for severe COVID-19. Between 2019 and 2020, encounters increased (17.7%, increasing to 23.5% of active DC Cohort participants had an encounter) while laboratory utilization decreased (14.4%, decreasing to 11.4% of active DC Cohort participants had an HIV RNA test performed). Implications of our work include the importance of protecting vulnerable people with HIV from acquiring COVID-19 and potentially manifesting severe complications through strategies including vaccination. Additionally, acknowledging that HIV service delivery will likely be changed long-term by the pandemic, adaptation is required to ensure continued progress towards 90-90-90 goals.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: AIDS Behav Journal subject: Behavioral Sciences / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article Affiliation country: S10461-022-03662-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: AIDS Behav Journal subject: Behavioral Sciences / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article Affiliation country: S10461-022-03662-0